Literature DB >> 29313882

Potential contribution of SET and c-MYC deregulation to promote extracellular matrix remodelling in hepatocellular carcinoma.

Ion Cristóbal1, Blanca Torrejón1, Federico Rojo2, Jesús García-Foncillas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29313882      PMCID： PMC5773959          DOI： 10.1111/bph.14108

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity.

Authors:  S W Al-Murrani; J R Woodgett; Z Damuni
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

2.  Potential contribution of SET and c-MYC deregulation to promote extracellular matrix remodelling in hepatocellular carcinoma.

Authors:  Ion Cristóbal; Blanca Torrejón; Federico Rojo; Jesús García-Foncillas
Journal:  Br J Pharmacol       Date:  2018-01-05       Impact factor: 8.739

3.  Stable SET knockdown in breast cell carcinoma inhibits cell migration and invasion.

Authors:  Jie Li; Xi-fei Yang; Xiao-hu Ren; Xiao-jing Meng; Hai-yan Huang; Qiong-hui Zhao; Jian-hui Yuan; Wen-xu Hong; Bo Xia; Xin-feng Huang; Li Zhou; Jian-jun Liu; Fei Zou
Journal:  Biochem Biophys Res Commun       Date:  2014-09-16       Impact factor: 3.575

4.  Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion.

Authors:  M P Ward; J P Spiers
Journal:  Br J Pharmacol       Date:  2017-04-07       Impact factor: 8.739

5.  Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of c-Myc.

Authors:  Richard Magid; T J Murphy; Zorina S Galis
Journal:  J Biol Chem       Date:  2003-06-19       Impact factor: 5.157

6.  Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.

Authors:  Hao Liu; Yixue Gu; Hongsheng Wang; Jiang Yin; Guopei Zheng; Zhijie Zhang; Minyin Lu; Chenkun Wang; Zhimin He
Journal:  Oncotarget       Date:  2015-06-20

7.  Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.

Authors:  Lays M Sobral; Lucas O Sousa; Ricardo D Coletta; Hamilton Cabral; Lewis J Greene; Eloiza H Tajara; J Silvio Gutkind; Carlos Curti; Andréia M Leopoldino
Journal:  Mol Cancer       Date:  2014-02-20       Impact factor: 27.401
  7 in total
  1 in total

1.  Potential contribution of SET and c-MYC deregulation to promote extracellular matrix remodelling in hepatocellular carcinoma.

Authors:  Ion Cristóbal; Blanca Torrejón; Federico Rojo; Jesús García-Foncillas
Journal:  Br J Pharmacol       Date:  2018-01-05       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.